PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.11%
Revenue growth under 50% of FSLR's 88.78%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
294.55%
Gross profit growth above 1.5x FSLR's 94.64%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-215.39%
Negative EBIT growth while FSLR is at 245.18%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-262.81%
Negative operating income growth while FSLR is at 245.18%. Joel Greenblatt would press for urgent turnaround measures.
-150.75%
Negative net income growth while FSLR stands at 221.43%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-149.67%
Negative EPS growth while FSLR is at 221.13%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-149.67%
Negative diluted EPS growth while FSLR is at 221.43%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.62%
Share count expansion well above FSLR's 0.20%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.62%
Diluted share count expanding well above FSLR's 0.03%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
120.36%
OCF growth at 50-75% of FSLR's 199.81%. Martin Whitman would question if the firm lags in monetizing sales effectively.
103.24%
FCF growth similar to FSLR's 94.99%. Walter Schloss would attribute it to parallel capital spending and operational models.
No Data
No Data available this quarter, please select a different quarter.
657.47%
5Y revenue/share CAGR under 50% of FSLR's 2284.47%. Michael Burry would suspect a significant competitive gap or product weakness.
53.03%
3Y revenue/share CAGR under 50% of FSLR's 168.71%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
127.48%
OCF/share CAGR of 127.48% while FSLR is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-88.02%
Negative 3Y OCF/share CAGR while FSLR stands at 37.47%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
-2819.21%
Negative 5Y net income/share CAGR while FSLR is 9529.78%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-1330.25%
Negative 3Y CAGR while FSLR is 84.41%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
72.75%
Below 50% of FSLR's 2058.68%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-3.62%
Negative 3Y equity/share growth while FSLR is at 170.75%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.64%
Firm’s AR is declining while FSLR shows 33.35%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
3.06%
Inventory shrinking or stable vs. FSLR's 34.02%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-5.28%
Negative asset growth while FSLR invests at 15.87%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-21.84%
We have a declining book value while FSLR shows 9.13%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
18.12%
Debt shrinking faster vs. FSLR's 68.60%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-16.98%
Our R&D shrinks while FSLR invests at 15.29%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-15.99%
We cut SG&A while FSLR invests at 21.71%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.